Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5221_Библиотеки_им_академика_М_И_Перельмана.pdf
Infectious Disease and Neurocognition
COMMITTEE ON THE DIAGNOSTIC CRITERIA FOR MYALGIC ENCEPHALOMYELITIS/
CHRONIC FATIGUE SYNDROME, BOARD ON THE HEALTH OF SELECT POPULATIONS
& INSTITUTE OF MEDICINE. 2015. Beyond Myalgic Encephalomyelitis/ Chronic Fatigue
Syndrome: Redening an Illness. Washington, DC: National Academies Press.
CONSTANT, E. L., ADAM, S., GILLAIN, B., LAMBERT, M., MASQUELIER, E. & SERON, X. 2011.
Cognitive decits in patients with chronic fatigue syndrome compared to those with major depressive disorder and healthy controls. Clin Neurol Neurosurg, 113, 295– 302.
CURATOLO, M., LA BIANCA, G., COSENTINO, G., BASCHI, R., SALEMI, G., TALOTTA, R.,
ROMANO, M., TRIOLO, G., DE TOMMASO, M., FIERRO, B. & BRIGHINA, F. 2017. Motor cortex
tRNS improves pain, aective and cognitive impairment in patients with bromyalgia: Preliminary
results of a randomised sham- controlled trial. Clin Exp Rheumatol, 35 Suppl 105, 100– 105.
CUTLER, S. J., VAYSSIER- TAUSSAT, M., ESTRADA- PEÑA, A., POTKONJAK, A., MIHALCA, A. D.
& ZELLER, H. 2021. Tick- borne diseases and co- infection: Current considerations. Ticks Tick Borne
Dis, 12, 101607.
D’SOUZA, R. S., WHIPPLE, M. O. & VINCENT, A. 2021. Statin therapy and symptom burden in pa-
tients with bromyalgia: A prospective questionnaire study. Mayo Clin Proc Innov Qual Outcomes,
5, 1036– 1041.
DALE, J. K., DI BISCEGLIE, A. M., HOOFNAGLE, J. H. & STRAUS, S. E. 1991. Chronic fatigue syn-
drome: Lack of association with hepatitis C virus infection. J Med Virol, 34, 119– 121.
DAMIANO, R. F., GUEDES, B. F., DE ROCCA, C. C., DE PÁDUA SERAFIM, A., CASTRO, L. H. M.,
MUNHOZ, C. D., NITRINI, R., FILHO, G. B., MIGUEL, E. C., LUCCHETTI, G. & FORLENZA, O.
2022. Cognitive decline following acute viral infections: Literature review and projections for postCOVID- 19. Eur Arch Psychiatry Clin Neurosci, 272, 139– 154.
DAVIS, A. P., MAXWELL, C. L., MENDOZA, H., CROOKS, A., DUNAWAY, S. B., STOREY, S.,
STEVENS, C., TANTALO, L. C., SAHI, S. K., ROBERTSON, K. R. & MARRA, C. M. 2021. Cognitive
impairment in syphilis: Does treatment based on cerebrospinal uid analysis improve outcome?
PLoS One, 16, e0254518.
DELGADO- ALONSO, C., VALLES- SALGADO, M., DELGADO- ÁLVAREZ, A., YUS, M., GÓMEZ-
RUIZ, N., JORQUERA, M., POLIDURA, C., GIL, M. J., MARCOS, A., MATÍAS- GUIU, J. &
MATÍAS- GUIU, J. A. 2022. Cognitive dysfunction associated with COVID- 19: A comprehensive
neuropsychological study. J Psychiatr Res, 150, 40– 46.
DEVANAND, D. P. 2016. Olfactory identication decits, cognitive decline, and dementia in older
adults. Am J Geriatr Psychiatry, 24, 1151– 1157.
DICK, B., ECCLESTON, C. & CROMBEZ, G. 2002. Attentional functioning in bromyalgia, rheuma-
toid arthritis, and musculoskeletal pain patients. Arthritis Rheum, 47, 639– 644.
DOWSETT, E. G., RAMSAY, A. M., MCCARTNEY, R. A. & BELL, E. J. 1990. Myalgic
encephalomyelitis— A persistent enteroviral infection? Postgrad Med J, 66, 526– 530.
ENBOM, M., LINDE, A. & EVENGÅRD, B. 2000. No evidence of active infection with human herpes-
virus 6 (HHV- 6) or HHV- 8 in chronic fatigue syndrome. J Clin Microbiol, 38, 2457.
ENDRESEN, G. K. 2003. Mycoplasma blood infection in chronic fatigue and bromyalgia syndromes.
Rheumatol Int, 23, 211– 215.
EVENGÅRD, B., BRIESE, T., LINDH, G., LEE, S. & LIPKIN, W. I. 1999. Absence of evidence of Borna
disease virus infection in Swedish patients with chronic fatigue syndrome. J Neurovirol, 5, 495– 499.
EZEAMAMA, A. E., FRIEDMAN, J. F., ACOSTA, L. P., BELLINGER, D. C., LANGDON, G. C.,
MANALO, D. L., OLVEDA, R. M., KURTIS, J. D. & MCGARVEY, S. T. 2005. Helminth infection and
cognitive impairment among Filipino children. Am J Trop Med Hyg, 72, 540– 548.
FERRUCCI, R., DINI, M., ROSCI, C., CAPOZZA, A., GROPPO, E., REITANO, M. R., ALLOCCO,
E., POLETTI, B., BRUGNERA, A., BAI, F., MONTI, A., TICOZZI, N., SILANI, V., CENTANNI, S.,
D’ARMINIO MONFORTE, A., TAGLIABUE, L. & PRIORI, A. 2022. One- year cognitive follow- up
of COVID- 19 hospitalized patients. Eur J Neurol, 29, 2006– 2014.
FOCK, R. R. E. & KRUEGER, G. R. F. 1994. Chronic fatigue syndrome: EineStandortbestimmung.
Dtsch Aerztebl, 91, 2946– 2953.
FRIEDMAN, K. J., FENNELL, P. A., PHEBY, D. F. H., SPIVACK, E., OLESKE, J. M., KLIMAS, N.,
ZALEWSKI, P. 2022. Topical Collection: Why Some Patients Never Fully Recover: Post Active Phase of
Fibromyalgia and Chronic Fatigue 409
Infection Syndromes (PAPIS) [Online]. MDPI Journals. Available: https:// www.mdpi.com/ jour nal/
hea lthc are/ topi cal_ coll ecti ons/ PAPIS [Accessed June 1, 2023].
FRIEDMAN, K. J., MUROVSKA, M., PHEBY, D. F. H. & ZALEWSKI, P. 2021. Our evolving under-
standing of ME/ CFS. Medicina (Kaunas), 57, 200.
FUKUDA, K., STRAUS, S. E., HICKIE, I., SHARPE, M. C., DOBBINS, J. G. & KOMAROFF, A. 1994.
e chronic fatigue syndrome: A comprehensive approach to its denition and study. International
Chronic Fatigue Syndrome Study Group. Ann Intern Med, 121, 953– 959.
GALVEZ- SÁNCHEZ, C. M., MUÑOZ LADRÓN DE GUEVARA, C., MONTORO, C. I.,
FERNÁNDEZ- SERRANO, M. J., DUSCHEK, S. & REYES DEL PASO, G. A. 2018. Cognitive decits
in bromyalgia syndrome are associated with pain responses to low intensity pressure stimulation.
PLoS One, 13, e0201488.
GARCÍA- SÁNCHEZ, C., CALABRIA, M., GRUNDEN, N., PONS, C., ARROYO, J. A., GÓMEZ-
ANSON, B., LLEÓ, A., ALCOLEA, D., BELVÍS, R., MOROLLÓN, N., MUR, I., POMAR, V. &
DOMINGO, P. 2022. Neuropsychological decits in patients with cognitive complaints aer
COVID- 19. Brain Behav, 12, e2508.
GASCÓN, J., MARCOS, T., VIDAL, J., GARCIA- FORCADA, A. & CORACHÁN, M. 1995.
Cytomegalovirus and Epstein- Barr Virus infection as a cause of chronic fatigue syndrome in travelers to tropical countries. J Travel Med, 2, 41– 44.
GE, L., D’SOUZA, R. S., OH, T., VINCENT, A., MOHABBAT, A. B., ELDRIGE, J., JIANG, L.,
WHIPPLE, M. O., MCALLISTER, S. J., WANG, Z., QU, W. & MAUCK, W. D. 2019. Tobacco use in
bromyalgia is associated with cognitive dysfunction: A prospective questionnaire study. Mayo Clin
Proc Innov Qual Outcomes, 3, 78– 85.
GELONCH, O., GAROLERA, M., ROSSELLÓ, L. & PIFARRÉ, J. 2013. [Cognitive dysfunction in bro-
myalgia]. Rev Neurol, 56, 573– 588.
GELONCH, O., GAROLERA, M., VALLS, J., CASTELLÀ, G., VARELA, O., ROSSELLÓ, L. & PIFARRE, J.
2018. e eect of depressive symptoms on cognition in patients with bromyalgia. PLoS One, 13, e0200057.
GELONCH, O., GAROLERA, M., VALLS, J., ROSSELLÓ, L. & PIFARRÉ, J. 2017. Cognitive complaints
in women with bromyalgia: Are they due to depression or to objective cognitive dysfunction? J Clin
Exp Neuropsychol, 39, 1013– 1025.
GÉRARD, H. C., WILDT, K. L., WHITTUM- HUDSON, J. A., LAI, Z., AGER, J. & HUDSON, A. P.
2005. e load of Chlamydia pneumoniae in the Alzheimer’s brain varies with APOE genotype.
Microb Pathog, 39, 19– 26.
GIL- UGIDOS, A., RODRÍGUEZ- SALGADO, D., PIDAL- MIRANDA, M., SAMARTIN- VEIGA, N.,
FERNÁNDEZ- PRIETO, M. & CARRILLO- DE- LA- PEÑA, M. T. 2021. Working memory performance, pain and associated clinical variables in women with bromyalgia. Front Psychol, 12, 747533.
GILLIAM, A. G. 1938. Epidemiological Study of an Epidemic, Diagnosed as Poliomyelitis, Occurring
Among the Personnel of the Los Angeles County General Hospital During the Summer of 1934.
Washington, DC: US Government Printing Oce.
GLASS, J. M. 2006. Cognitive dysfunction in bromyalgia and chronic fatigue syndrome: New trends
and future directions. Curr Rheumatol Rep, 8, 425– 429.
GLASS, J. M. 2009. Review of cognitive dysfunction in bromyalgia: A convergence on working
memory and attentional control impairments. Rheum Dis Clin North Am, 35, 299– 311.
GLASS, J. M. & PARK, D. C. 2001. Cognitive dysfunction in bromyalgia. Curr Rheumatol Rep, 3, 123– 127.
GONZALEZ, K. I. & TADI, P. 2023. Cognitive Assessment [Online]. StatPearls Publishing.
Available: https:// www.ncbi.nlm.nih.gov/ books/ NBK556 049/ [Accessed December 1, 2023].
GONZÁLEZ- VILLAR, A. J., SAMARTIN- VEIGA, N., ARIAS, M. & CARRILLO- DE- LA- PEÑA, M.
T. 2017. Increased neural noise and impaired brain synchronization in bromyalgia patients during
cognitive interference. Sci Rep, 7, 5841.
GOW, J. W., SIMPSON, K., BEHAN, P. O., CHAUDHURI, A., MCKAY, I. C. & BEHAN, W. M. 2001.
Antiviral pathway activation in patients with chronic fatigue syndrome and acute infection. Clin
Infect Dis, 33, 2080– 2081.
HAMPSHIRE, A., TRENDER, W., CHAMBERLAIN, S. R., JOLLY, A. E., GRANT, J. E., PATRICK, F.,
MAZIBUKO, N., WILLIAMS, S. C., BARNBY, J. M., HELLYER, P. & MEHTA, M. A. 2021. Cognitive
decits in people who have recovered from COVID- 19. EClinicalMedicine, 39, 101044.
Infectious Disease and Neurocognition
HANSON, S. W., ABBAFATI, C., AERTS, J. G., AL- ALY, Z., ASHBAUGH, C., BALLOUZ, T., BLYUSS,
O., BOBKOVA, P., BONSEL, G., BORZAKOVA, S., BUONSENSO, D., BUTNARU, D., CARTER,
A., CHU, H., DE ROSE, C., DIAB, M. M., EKBOM, E., EL TANTAWI, M., FOMIN, V., FRITHIOF,
R., GAMIROVA, A., GLYBOCHKO, P. V., HAAGSMA, J. A., HAGHJOOY JAVANMARD, S.,
HAMILTON, E. B., HARRIS, G., HEIJENBROK- KAL, M. H., HELBOK, R., HELLEMONS,
M. E., HILLUS, D., HUIJTS, S. M., HULTSTRÖM, M., JASSAT, W., KURTH, F., LARSSON, I.
M., LIPCSEY, M., LIU, C., LOFLIN, C. D., MALINOVSCHI, A., MAO, W., MAZANKOVA, L.,
MCCULLOCH, D., MENGES, D., MOHAMMADIFARD, N., MUNBLIT, D., NEKLIUDOV, N. A.,
OGBUOJI, O., OSMANOV, I. M., PEÑALVO, J. L., PETERSEN, M. S., PUHAN, M. A., RAHMAN,
M., RASS, V., REINIG, N., RIBBERS, G. M., RICCHIUTO, A., RUBERTSSON, S., SAMITOVA,
E., SARRAFZADEGAN, N., SHIKHALEVA, A., SIMPSON, K. E., SINATTI, D., SORIANO, J. B.,
SPIRIDONOVA, E., STEINBEIS, F., SVISTUNOV, A. A., VALENTINI, P., VAN DE WATER, B. J.,
VAN DEN BERG- EMONS, R., WALLIN, E., WITZENRATH, M., WU, Y., XU, H., ZOLLER, T.,
ADOLPH, C., ALBRIGHT, J., AMLAG, J. O., ARAVKIN, A. Y., BANG- JENSEN, B. L., BISIGNANO,
C., CASTELLANO, R., CASTRO, E., CHAKRABARTI, S., COLLINS, J. K., DAI, X., DAOUD,
F., DAPPER, C., DEEN, A., DUNCAN, B. B., ERICKSON, M., EWALD, S. B., FERRARI, A. J.,
FLAXMAN, A. D., FULLMAN, N., GAMKRELIDZE, A., GILES, J. R., GUO, G., HAY, S. I., HE, J.,
HELAK, M., et al. 2022. Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID- 19 in 2020 and 2021. JAMA,
328, 1604– 1615.
HÄUSER, W. & FITZCHARLES, M. A. 2018. Facts and myths pertaining to bromyalgia. Dialogues
Clin Neurosci, 20, 53– 62.
HENEINE, W., WOODS, T. C., SINHA, S. D., KHAN, A. S., CHAPMAN, L. E., SCHONBERGER, L. B.
& FOLKS, T. M. 1994. Lack of evidence for infection with known human and animal retroviruses in
patients with chronic fatigue syndrome. Clin Infect Dis, 18 Suppl 1, S121– 125.
HENNEGHAN, A. M., LEWIS, K. A., GILL, E. & KESLER, S. R. 2022. Cognitive impairment in non-
critical, mild- to- moderate COVID- 19 survivors. Front Psychol, 13, 770459.
HERNANDEZ- RUIZ, V., LETENNEUR, L., FÜLÖP, T., HELMER, C., ROUBAUD- BAUDRON, C.,
AVILA- FUNES, J. A. & AMIEVA, H. 2022. Infectious diseases and cognition: Do we have to worry?
Neurol Sci, 43, 6215– 6224.
HOLMES, G. P., KAPLAN, J. E., GANTZ, N. M., KOMAROFF, A. L., SCHONBERGER, L. B., STRAUS,
S. E., JONES, J. F., DUBOIS, R. E., CUNNINGHAM- RUNDLES, C., PAHWA, S. 1988. Chronic fatigue syndrome: A working case denition. Ann Intern Med, 108, 387– 389.
IBRAHEEM, W., MCKENZIE, S., WILCOX- OMUBO, V., ABDELATY, M., SAJI, S. E., SIBY, R.,
ALALYANI, W. & MOSTAFA, J. A. 2021. Pathophysiology and clinical implications of cognitive dysfunction in bromyalgia. Cureus, 13, e19123.
ILARIA, R. L., JR., KOMAROFF, A. L., FAGIOLI, L. R., MOLONEY, W. C., TRUE, C. A. & NAIDES,
S. J. 1995. Absence of parvovirus B19 infection in chronic fatigue syndrome. Arthritis Rheum, 38,
638– 641.
INNES, K. E. & SAMBAMOORTHI, U. 2020. e potential contribution of chronic pain and common
chronic pain conditions to subsequent cognitive decline, new onset cognitive impairment, and incident dementia: A systematic review and conceptual model for future research. J Alzheimers Dis, 78,
1177– 1195.
IRIE, H., HARADA, Y., YOSHIHASHI, H., KIMURA, T., KOJIMA, M., KATAOKA, M., SAITO, M.,
SUGAWARA, Y. & MORI, W. 1989. Spread of herpes simplex virus type- 1 (Miyama + GC strain) to
the central nervous system aer intraperitoneal inoculation: e role of the myenteric plexus of the
gut. Arch Virol, 105, 247– 257.
ITZHAKI, R. F. & WOZNIAK, M. A. 2007. Viral infection and cognitive decline. J Am Geriatr Soc,
55, 131.
IWAKAMI, E., ARASHIMA, Y., KATO, K., KOMIYA, T., MATSUKAWA, Y., IKEDA, T., ARAKAWA,
Y. & OSHIDA, S. 2005. Treatment of chronic fatigue syndrome with antibiotics: Pilot study assessing
the involvement of Coxiella burnetii infection. Intern Med, 44, 1258– 1263.
JACOBSON, S. K., DALY, J. S., THORNE, G. M. & MCINTOSH, K. 1997. Chronic parvovirus B19 infec-
tion resulting in chronic fatigue syndrome: Case history and review. Clin Infect Dis, 24, 1048– 1051.
Fibromyalgia and Chronic Fatigue 411
JASON, L. A., JORDAN, K., MIIKE, T., BELL, D. S., LAPP, C., TORRES- HARDING, S., ROWE, K.,
GURWITT, A., DE MEIRLEIR, K. & VAN HOOF, E. L. S. 2006. A pediatric case denition for my-
algic encephalomyelitis and chronic fatigue syndrome. J Chronic Fatigue Syndr, 13, 1– 44.
JONCAS, J. H. 1991. Search for an association between Epstein- Barr virus infection and the chronic
fatigue syndrome. Can Dis Wkly Rep, 17 Suppl 1E, 43– 47.
JOO, T., LEE, Y. C. & KIM, T. G. 2019. Herpes zoster involving the abducens and vagus nerves without
typical skin rash: A case report and literature review. Medicine (Baltimore), 98, e15619.
JOSEV, E. K., MALPAS, C. B., SEAL, M. L., SCHEINBERG, A., LUBITZ, L., ROWE, K. & KNIGHT,
S. J. 2020. Resting- state functional connectivity, cognition, and fatigue in response to cognitive
exertion: A novel study in adolescents with chronic fatigue syndrome. Brain Imaging Behav, 14,
1815– 1830.
JOUSTRA, M. L., HARTMAN, C. A., BAKKER, S. J. L. & ROSMALEN, J. G. M. 2022. Cognitive task
performance and subjective cognitive symptoms in individuals with chronic fatigue syndrome or -
bromyalgia: A cross- sectional analysis of the Lifelines Cohort Study. Psychosom Med, 84, 1087– 1095.
KARPER, W. B. 2007. Fibromyalgia, cognitive problems and independence: Physical activity may be
useful in home health care. Home Health Care Serv Q, 26, 19– 28.
KATO, Y. H., YAMATE, M., TSUJIKAWA, M., NISHIGAKI, H., TANAKA, Y., YUNOKI, M.,
KURATSUNE, H., WATANABE, Y. & IKUTA, K. 2009. No apparent dierence in the prevalence of
parvovirus B19 infection between chronic fatigue syndrome patients and healthy controls in Japan.
J Clin Virol, 44, 246– 247.
KATZ, R. S., HEARD, A. R., MILLS, M. & LEAVITT, F. 2004. e prevalence and clinical impact of
reported cognitive diculties (brofog) in patients with rheumatic disease with and without bro-
myalgia. J Clin Rheumatol, 10, 53– 58.
KAWATANI, J., MIZUNO, K., SHIRAISHI, S., TAKAO, M., JOUDOI, T., FUKUDA, S., WATANABE,
Y. & TOMODA, A. 2011. Cognitive dysfunction and mental fatigue in childhood chronic fatigue
syndrome— A 6- month follow- up study. Brain Dev, 33, 832– 841.
KERR, J. R., BRACEWELL, J., LAING, I., MATTEY, D. L., BERNSTEIN, R. M., BRUCE, I. N. &
TYRRELL, D. A. 2002. Chronic fatigue syndrome and arthralgia following parvovirus B19 infection.
J Rheumatol, 29, 595– 602.
KERR, J. R. & TYRRELL, D. A. 2003. Cytokines in parvovirus B19 infection as an aid to understanding
chronic fatigue syndrome. Curr Pain Headache Rep, 7, 333– 341.
KITANI, T., KURATSUNE, H., FUKE, I., NAKAMURA, Y., NAKAYA, T., ASAHI, S., TOBIUME, M.,
YAMAGUTI, K., MACHII, T., INAGI, R., YAMANISHI, K. & IKUTA, K. 1996. Possible correla-
tion between Borna disease virus infection and Japanese patients with chronic fatigue syndrome.
Microbiol Immunol, 40, 459– 462.
KOELLE, D. M., BARCY, S., HUANG, M. L., ASHLEY, R. L., COREY, L., ZEH, J., ASHTON, S. &
BUCHWALD, D. 2002. Markers of viral infection in monozygotic twins discordant for chronic fa-
tigue syndrome. Clin Infect Dis, 35, 518– 525.
KOMAROFF, A. L. & CHO, T. A. 2011. Role of infection and neurologic dysfunction in chronic fatigue
syndrome. Semin Neurol, 31, 325– 337.
KOMAROFF, A. L., WANG, S. P., LEE, J. & GRAYSTON, J. T. 1992. No association of chronic
Chlamydia pneumoniae infection with chronic fatigue syndrome. J Infect Dis, 165, 184.
KRATZ, A. L., WHIBLEY, D., KIM, S., SLIWINSKI, M., CLAUW, D. & WILLIAMS, D. A. 2020.
Fibrofog in daily life: An examination of ambulatory subjective and objective cognitive function in
bromyalgia. Arthritis Care Res (Hoboken), 72, 1669– 1677.
KRUEGER, G. R., KOCH, B., HOFFMANN, A., ROJO, J., BRANDT, M. E., WANG, G. & BUJA, L.
M. 2001. Dynamics of chronic active herpesvirus- 6 infection in patients with chronic fatigue syn-
drome: Data acquisition for computer modeling. In Vivo, 15, 461– 465.
LARKIN, H. D. 2023. Patients with mild COVID- 19 at risk of some post- COVID- 19 condition symp-
toms. JAMA, 329, 364.
LEAVITT, F. & KATZ, R. S. 2008. Speed of mental operations in bromyalgia: A selective naming speed
decit. J Clin Rheumatol, 14, 214– 218.
LEAVITT, F. & KATZ, R. S. 2014. Cognitive dysfunction in bromyalgia: Slow access to the mental lex-
icon. Psychol Rep, 115, 828– 839.
Infectious Disease and Neurocognition
LI, Y. J., WANG, D. X., BAI, X. L., CHEN, J., LIU, Z. D., FENG, Z. J. & ZHAO, Y. M. 2005. [Clinical char-
acteristics of patients with chronic fatigue syndrome: Analysis of 82 cases]. Zhonghua Yi Xue Za Zhi,
85, 701– 704.
LIEW, T. M., FENG, L., GAO, Q., NG, T. P. & YAP, P. 2015. Diagnostic utility of Montreal Cognitive
Assessment in the h edition of Diagnostic and Statistical Manual of Mental Disorders: Major and
mild neurocognitive disorders. J Am Med Dir Assoc, 16, 144– 148.
LIM, E. J. & SON, C. G. 2020. Review of case denitions for myalgic encephalomyelitis/ chronic fatigue
syndrome (ME/ CFS). J Transl Med, 18, 289.
LIN, Y. J., KO, Y. C., CHOW, L. H., HSIAO, F. J., LIU, H. Y., WANG, P. N. & CHEN, W. T. 2021. Salivary
cortisol is associated with cognitive changes in patients with bromyalgia. Sci Rep, 11, 1311.
LINDE, A., ANDERSSON, B., SVENSON, S. B., AHRNE, H., CARLSSON, M., FORSBERG, P., HUGO,
H., KARSTORP, A., LENKEI, R., LINDWALL, A., LOFTENIUS, A., SÄIL, C. & ANDERSSON, J.
1992. Serum levels of lymphokines and soluble cellular receptors in primary Epstein- Barr virus in-
fection and in patients with chronic fatigue syndrome. J Infect Dis, 165, 994– 1000.
LINDQUIST, L. & VAPALAHTI, O. 2008. Tick- borne encephalitis. Lancet, 371, 1861– 1871.
MAGNUS, P., GUNNES, N., TVEITO, K., BAKKEN, I. J., GHADERI, S., STOLTENBERG, C.,
HORNIG, M., LIPKIN, W. I., TROGSTAD, L. & HÅBERG, S. E. 2015. Chronic fatigue syndrome/
myalgic encephalomyelitis (CFS/ ME) is associated with pandemic inuenza infection, but not with
an adjuvanted pandemic inuenza vaccine. Vaccine, 33, 6173– 6177.
MARSHALL- GRADISNIK, S. & EATON- FITCH, N. 2022. Understanding myalgic encephalomyelitis.
Science, 377, 1150– 1151.
MATANO, S., KINOSHITA, H., TANIGAWA, K., TERAHATA, S. & SUGIMOTO, T. 2003. Acute par-
vovirus B19 infection mimicking chronic fatigue syndrome. Intern Med, 42, 903– 905.
MCARDLE, A., MCARDLE, F., JACKSON, M., PAGE, S., FAHAL, I. & EDWARDS, R. 1996.
Investigation by polymerase chain reaction of enteroviral infection in patients with chronic fatigue
syndrome. Clin Sci, 90, 295– 300.
MEDINA, L. D., HIRSHBERG, L., TAYLOR, M. J., GILBERT, P. E. & HEATON, R. K. 2019. Rates of
neuropsychological dysfunction in bromyalgia and rheumatoid arthritis: An automated clinical
rating approach. J Clin Rheumatol, 25, 252– 257.
MICHIELS, V. & CLUYDTS, R. 2001. Neuropsychological functioning in chronic fatigue syndrome: A
review. Acta Psychiatr Scand, 103, 84– 93.
MICHIELS, V., DE GUCHT, V., CLUYDTS, R. & FISCHLER, B. 1999. Attention and information pro-
cessing eciency in patients with chronic fatigue syndrome. J Clin Exp Neuropsychol, 21, 709– 729.
MIKOVITS, J. A., HUANG, Y., PFOST, M. A., LOMBARDI, V. C., BERTOLETTE, D. C., HAGEN, K. S.
& RUSCETTI, F. W. 2010. Distribution of xenotropic murine leukemia virus- related virus (XMRV)
infection in chronic fatigue syndrome and prostate cancer. AIDS Rev, 12, 149– 152.
MINELLI, A. & VAONA, A. 2012. Eectiveness of cognitive behavioral therapy in the treatment of -
bromyalgia syndrome: A meta- analytic literature review. Reumatismo, 64, 151– 157.
MIRÓ, E., LUPIÁÑEZ, J., MARTÍNEZ, M., SÁNCHEZ, A., DÍAZ- PIEDRA, C., GUZMÁN, M. &
BUELA- CASAL, G. 2011. Cognitive- behavioral therapy for insomnia improves attentional function
in bromyalgia syndrome: A pilot, randomized controlled trial. J Health Psychol, 16, 770– 782.
MORRISON, L. A., SIDMAN, R. L. & FIELDS, B. N. 1991. Direct spread of reovirus from the intestinal
lumen to the central nervous system through vagal autonomic nerve bers. Proc Natl Acad Sci U S A,
88, 3852– 3856.
MOZHGANI, S.- H., RAJABI, F., QURBANI, M., ERFANI, Y., YASLIANIFARD, S., MOOSAVI, A.,
POURROSTAMI, K., BARADARAN BAGHERI, A., SOLEIMANI, A. & BEHZADIAN, F. 2022.
Human herpesvirus 6 infection and risk of chronic fatigue syndrome: A systematic review and meta-
analysis. Intervirology, 65, 49– 57.
MUÑOZ LADRÓN DE GUEVARA, C., FERNÁNDEZ- SERRANO, M. J., REYES DEL PASO, G. A. &
DUSCHEK, S. 2018. Executive function impairments in bromyalgia syndrome: Relevance of clin-
ical variables and body mass index. PLoS One, 13, e0196329.
MUZAMBI, R., BHASKARAN, K., BRAYNE, C., SMEETH, L. & WARREN- GASH, C. 2019. Common
bacterial infections and risk of incident cognitive decline or dementia: A systematic review protocol.
BMJ Open, 9, e030874.
Fibromyalgia and Chronic Fatigue 413
NAGARAJAN, N., ASSI, L., VARADARAJ, V., MOTAGHI, M., SUN, Y., COUSER, E., EHRLICH, J.
R., WHITSON, H. & SWENOR, B. K. 2022. Vision impairment and cognitive decline among older
adults: A systematic review. BMJ Open, 12, e047929.
NAKAYA, T., TAKAHASHI, H., NAKAMURA, Y., KURATSUNE, H., KITANI, T., MACHII, T.,
YAMANISHI, K. & IKUTA, K. 1999. Borna disease virus infection in two family clusters of patients
with chronic fatigue syndrome. Microbiol Immunol, 43, 679– 689.
NAVIDAD, A. L., SAMBEAT M. A. & FARRERONS, J. 1990. [Chronic infection caused by Epstein-
Barr virus and chronic fatigue syndrome]. Med Clin (Barc), 94, 315– 316.
NETO, N. S. R., GAUDITANO, G. & YOSHINARI, N. H. 2014. Chronic lymphomonocytic meningo-
encephalitis, oligoarthritis and erythema nodosum: Report of Baggio- Yoshinari syndrome of long
and relapsing evolution. Rev Brasil Reumatol (Engl Ed), 54, 148– 151.
NISHIOKA, K., HAYASHI, T., SUZUKI, M., LI, Y., NAKAYAMA, S., MATSUSHIMA, T., USUI, C.,
SHIBATA, N., MOTOI, Y., TANAKA, R., NISHIOKA, K. & HATTORI, N. 2016. Fibromyalgia syndrome and cognitive dysfunction in elderly: A case series. Int J Rheumat Dis, 19, 21– 29.
O’NEAL, A. J. & HANSON, M. R. 2021. e enterovirus theory of disease etiology in myalgic encepha-
lomyelitis/ chronic fatigue syndrome: A critical review. Front Med, 908, 688486.
OKANO, M. 1992. Viral infection and its causative role for chronic fatigue syndrome. Nihon Rinsho,
50, 2617– 2624.
OLLILA, H., PIHLAJA, R., KOSKINEN, S., TUULIO- HENRIKSSON, A., SALMELA, V., TIAINEN,
M., HOKKANEN, L. & HÄSTBACKA, J. 2022. Long- term cognitive functioning is impaired in
ICU- treated COVID- 19 patients: A comprehensive controlled neuropsychological study. Crit Care,
26, 223.
OTERO, E., GÁLVEZ, I., ORTEGA, E. & HINCHADO, M. D. 2023. Inuence of chronic fa-
tigue syndrome codiagnosis on the relationship between perceived and objective psychoneuroimmunoendocrine disorders in women with bromyalgia. Biomedicines, 11, 1488.
PABALAN, N., SINGIAN, E., TABANGAY, L., JARJANAZI, H., BOIVIN, M. J. & EZEAMAMA, A. E.
2018. Soil- transmitted helminth infection, loss of education and cognitive impairment in schoolaged children: A systematic review and meta- analysis. PLoS Negl Trop Dis, 12, e0005523.
PAPIS TOPICAL COLLECTION. 2021. Why Some Patients Never Fully Recover: Post Active
Phase of Infection Syndromes (PAPIS) [Online]. Multidisciplinary Digital Publishing Institute.
Available: https:// www.mdpi.com/ jour nal/ hea lthc are/ topi cal_ coll ecti ons/ PAPIS
PARRAS, F., SALVÁ, F., REINA, J., GIL, J., PORTELA, D. & ALOMAR, P. 1989. Chronic fatigue syn-
drome associated with Epstein- Barr virus infection. Med Clin, 92, 619– 622.
PERROTTELLI, A., SANSONE, N., GIORDANO, G. M., CAPORUSSO, E., GIULIANI, L., MELILLO,
A., PEZZELLA, P., BUCCI, P., MUCCI, A. & GALDERISI, S. 2022. Cognitive impairment aer postacute COVID- 19 infection: A systematic review of the literature. J Pers Med, 12, 2070.
PIDAL- MIRANDA, M., GONZÁLEZ- VILLAR, A. J., CARRILLO- DE- LA- PEÑA, M. T., ANDRADE,
E. & RODRÍGUEZ- SALGADO, D. 2018. Broad cognitive complaints but subtle objective working
memory impairment in bromyalgia patients. PeerJ, 6, e5907.
POLLARK, R. J., KOMAROFF, A. L., TELFORD, S. R., 3RD, GLEIT, FAGIOLI, L., BRUNET, L. R. &
SPIELMAN, A. 1995. Borrelia burgdorferi infection is rarely found in patients with chronic fatigue
syndrome. Clin Infect Dis, 20, 467– 468.
PURTILO, D. 1991. Dual infections of the immune system in patients with chronic active Epstein- Barr
virus infection mimicking chronic fatigue syndrome. Can Dis Wkly Rep, 17, 29– 32.
QU, P., YU, J.- X. & CHEN, G.- H. 2021. Neuroendocrine modulation of cognitive performance in the
patients with bromyalgia. Eur Neurol, 84, 254– 264.
RACCIATTI, D., GORGORETTI, V., SEPEDE, G., GAMBI, F. & PIZZIGALLO, E. 2011. An Italian
study on health- related quality of life and fatigue in patients with chronic fatigue syndrome and patients with chronic HCV virus infection: Similarities and dierences. Int J Immunopathol Pharmacol,
24, 673– 681.
RASA, S., NORA- KRUKLE, Z., HENNING, N., ELIASSEN, E., SHIKOVA, E., HARRER, T.,
SCHEIBENBOGEN, C., MUROVSKA, M., PRUSTY, B. K. & EUROPEAN NETWORK ON ME/
CFS (EUROMENE). 2018. Chronic viral infections in myalgic encephalomyelitis/ chronic fatigue
syndrome (ME/ CFS). J Transl Med, 16, 1– 25.
Infectious Disease and Neurocognition
RASOULI, O., GOTAAS, M. E., STENSDOTTER, A.- K., SKOVLUND, E., LANDRØ, N. I., DÅSTØL,
P. & FORS, E. A. 2019. Neuropsychological dysfunction in chronic fatigue syndrome and the relation
between objective and subjective ndings. Neuropsychology, 33, 658.
REEVES, W. C., LLOYD, A., VERNON, S. D., KLIMAS, N., JASON, L. A., BLEIJENBERG, G.,
EVENGARD, B., WHITE, P. D., NISENBAUM, R. & UNGER, E. R. 2003. Identication of ambigu-
ities in the 1994 chronic fatigue syndrome research case denition and recommendations for resolu-
tion. BMC Health Serv Res, 3, 25.
ROBINSON, L. J., GALLAGHER, P., WATSON, S., PEARCE, R., FINKELMEYER, A., MACLACHLAN,
L. & NEWTON, J. L. 2019. Impairments in cognitive performance in chronic fatigue syndrome are
common, not related to co- morbid depression but do associate with autonomic dysfunction. PLoS
One, 14, e0210394.
RUIZ- PABLOS, M., PAIVA, B., MONTERO- MATEO, R., GARCIA, N. & ZABALETA, A. 2021.
Epstein- Barr virus and the origin of myalgic encephalomyelitis or chronic fatigue syndrome. Front
Immunol, 12, 656797.
SAMARTIN- VEIGA, N., GONZÁLEZ- VILLAR, A. J. & CARRILLO- DE- LA- PEÑA, M. T. 2019.
Neural correlates of cognitive dysfunction in bromyalgia patients: Reduced brain electrical activity
during the execution of a cognitive control task. Neuroimage Clin, 23, 101817.
SANTAMARINA- PEREZ, P., EIROA- OROSA, F. J., FRENICHE, V., MORENO- MAYOS, A., ALEGRE,
J., SAEZ, N. & JACAS, C. 2011. Length of illness does not predict cognitive dysfunction in chronic
fatigue syndrome. Appl Neuropsychol, 18, 216– 222.
SANTAMARINA- PEREZ, P., EIROA- OROSA, F. J., RODRIGUEZ- URRUTIA, A., QURESHI, A.
& ALEGRE, J. 2014. Neuropsychological impairment in female patients with chronic fatigue syn-
drome: A preliminary study. Appl Neuropsychol Adult, 21, 120– 127.
SANTOS, V. S. D. S. D., ZORTEA, M., ALVES, R. L., NAZIAZENO, C. C. D. S., SALDANHA, J. S.,
CARVALHO, S. D. C. R. D., LEITE, A. J. D. C., TORRES, I. L. D. S., SOUZA, A. D. & CALVETTI,
P. Ü. 2018. Cognitive eects of transcranial direct current stimulation combined with working
memory training in bromyalgia: A randomized clinical trial. Sci Rep, 8, 12477.
SAYLOR, D., DICKENS, A. M., SACKTOR, N., HAUGHEY, N., SLUSHER, B., PLETNIKOV, M.,
MANKOWSKI, J. L., BROWN, A., VOLSKY, D. J. & MCARTHUR, J. C. 2016. HIV- associated
neurocognitive disorder— Pathogenesis and prospects for treatment. Nat Rev Neurol, 12, 234– 248.
SCHIERHOUT, G., MCGREGOR, S., GESSAIN, A., EINSIEDEL, L., MARTINELLO, M. & KALDOR,
J. 2020. Association between HTLV- 1 infection and adverse health outcomes: A systematic review
and meta- analysis of epidemiological studies. Lancet Infect Dis, 20, 133– 143.
SCHOOLEY, R. 1988. Chronic fatigue syndrome: A manifestation of Epstein- Barr virus infection?
Curr Clin Topics Infect Dis, 9, 126– 146.
SEISHIMA, M., MIZUTANI, Y., SHIBUYA, Y. & ARAKAWA, C. 2008. Chronic fatigue syndrome aer
human parvovirus B19 infection without persistent viremia. Dermatology, 216, 341– 346.
SERRANO- CASTRO, P. J., GARZÓN- MALDONADO, F. J., CASADO- NARANJO, I., OLLERO-
ORTIZ, A., MÍNGUEZ- CASTELLANOS, A., IGLESIAS- ESPINOSA, M., BAENA- PALOMINO, P.,
SÁNCHEZ- SANCHEZ, V., SÁNCHEZ- PÉREZ, R. M., RUBI- CALLEJON, J., ESTÉVEZ- MARÍA, J. C.,
GALEANO- BILBAO, B., ROMERO- IMBRODA, J., SOBRINO, B., ARRABAL- GOMEZ, C., OLIVER-
MARTOS, B., MUÑOZ- BECERRA, L., REQUENA, N., GONZÁLEZ ÁLVAREZ DE SOTOMAYOR,
M. D. M., ESTIVILL- TORRUS, G., SUAREZ, J., CIANO- PETERSEN, N. L., PONS- PONS, G.,
REYES- BUENO, J. A., CABEZUDO- GARCIA, P., AGUILAR- CASTILLO, M. J., DE LA CRUZ
COSME, C., DUQUE- HOLGUERA, M., CUARTERO- RODRIGUEZ, E., VILCHES- CARRILLO,
R. M., CARRERA- MUÑOZ, I., CARNERO- PARDO, C., RAMIREZ- GARCIA, T., OROPESA, J. M.,
DOMINGUEZ- MAYORAL, A., PELAEZ- VIÑAS, N., VALIENTE, L. & DE FONSECA, F. R. 2022. e
cognitive and psychiatric subacute impairment in severe Covid- 19. Sci Rep, 12, 3563.
SERVATIUS, R. J., TAPP, W. N., BERGEN, M. T., POLLET, C. A., DRASTAL, S. D., TIERSKY, L. A.,
DESAI, P. & NATELSON, B. H. 1998. Impaired associative learning in chronic fatigue syndrome.
Neuroreport, 9, 1153– 1157.
SHAN, Z. Y., FINEGAN, K., BHUTA, S., IRELAND, T., STAINES, D. R., MARSHALL- GRADISNIK,
S. M. & BARNDEN, L. R. 2018. Brain function characteristics of chronic fatigue syndrome: A task
fMRI study. Neuroimage Clin, 19, 279– 286.
Fibromyalgia and Chronic Fatigue 415
SHAPIRO, J. S. 2009. Does varicella- zoster virus infection of the peripheral ganglia cause chronic fa-
tigue syndrome? Med Hypotheses, 73, 728– 734.
SHARPE, M. C., ARCHARD, L. C., BANATVALA, J. E., BORYSIEWICZ, L. K., CLARE, A. W., DAVID,
A., EDWARDS, R. H., HAWTON, K. E., LAMBERT, H. P. & LANE, R. J. 1991. A report— Chronic
fatigue syndrome: Guidelines for research. J R Soc Med, 84, 118– 121.
SHIKOVA, E., RESHKOVA, V., KUMANOVA, А., RALEVA, S., ALEXANDROVA, D., CAPO,
N., MUROVSKA, M. & THE EUROPEAN NETWORK ON ME/ CFS EUROMENE. 2020.
Cytomegalovirus, Epstein– Barr virus, and human herpesvirus- 6 infections in patients with myalgic
еncephalomyelitis/ chronic fatigue syndrome. J Med Virol, 92, 3682– 3688.
SHMYGALEV, S., DAGTEKIN, O., GERBERSHAGEN, H. J., MARCUS, H., JÜBNER, M.,
SABATOWSKI, R. & PETZKE, F. 2014. Assessing cognitive and psychomotor performance in patients with bromyalgia syndrome. Pain er, 3, 85– 101.
SIEGEL, S. D., ANTONI, M. H., FLETCHER, M. A., MAHER, K., SEGOTA, M. C. & KLIMAS, N.
2006. Impaired natural immunity, cognitive dysfunction, and physical symptoms in patients with
chronic fatigue syndrome: Preliminary evidence for a subgroup? J Psychosomat Res, 60, 559– 566.
SILVA, A. F., ZORTEA, M., CARVALHO, S., LEITE, J., TORRES, I. L. D. S., FREGNI, F. & CAUMO,
W. 2017. Anodal transcranial direct current stimulation over the le dorsolateral prefrontal cortex
modulates attention and pain in bromyalgia: Randomized clinical trial. Sci Rep, 7, 135.
SLETVOLD, H., STILES, T. & LANDRØ, N. 1995. Information processing in primary bromyalgia,
major depression and healthy controls. J Rheumatol, 22, 137– 142.
SMYTHE, H. A. 1979. “Fibrositis” as a disorder of pain modulation. Clin Rheumat Dis, 5, 823– 832.
SOLER- RANGEL, S., JIMÉNEZ- RESTREPO, N., NARIÑO, D. & ROSSELLI, D. 2020. Rabies enceph-
alitis and extra- neural manifestations in a patient bitten by a domestic cat. Rev Inst Med Trop São
Paulo, 62, e1.
STRAUS, S. E. 1993. Studies of herpesvirus infection in chronic fatigue syndrome. Ciba Found Symp,
173, 132– 139.
STRAUS, S. E., DALE, J. K., WRIGHT, R. & METCALFE, D. D. 1988. Allergy and the chronic fatigue
syndrome. J Allergy Clin Immunol, 81, 791– 795.
SULHEIM, D., FAGERMOEN, E., SIVERTSEN, Ø. S., WINGER, A., WYLLER, V. B. & ØIE, M. G.
2015. Cognitive dysfunction in adolescents with chronic fatigue: A cross- sectional study. Arch Dis
Child, 100, 838– 844.
SWITZER, W. M., JIA, H., HOHN, O., ZHENG, H., TANG, S., SHANKAR, A., BANNERT, N.,
SIMMONS, G., HENDRY, R. M. & FALKENBERG, V. R. 2010. Absence of evidence of xenotropic
murine leukemia virus- related virus infection in persons with chronic fatigue syndrome and healthy
controls in the United States. Retrovirology, 7, 1– 13.
TESIO, V., TORTA, D. M., COLONNA, F., LEOMBRUNI, P., GHIGGIA, A., FUSARO, E., GEMINIANI,
G. C., TORTA, R. & CASTELLI, L. 2015. Are bromyalgia patients cognitively impaired? Objective
and subjective neuropsychological evidence. Arthritis Care Res, 67, 143– 150.
TIERSKY, L. A., JOHNSON, S. K., LANGE, G., NATELSON, B. H. & DELUCA, J. 1997. Neuropsychology
of chronic fatigue syndrome: A critical review. J Clin Exp Neuropsychol, 19, 560– 586.
UCHIDA, Y., SUGIURA, S., NISHITA, Y., SAJI, N., SONE, M. & UEDA, H. 2019. Age- related hearing
loss and cognitive decline— e potential mechanisms linking the two. Auris Nasus Larynx, 46, 1– 9.
UNITED NATIONS. 2023. World Population to Reach 8 Billion on 15 November 2022 [Online]. United
Nations. Available: https:// www.un.org/ en/ desa/ world- pop ulat ion- reach- 8- bill ion- 15- novem ber-
2022 [Accessed January 17, 2023].
VAN CAMPEN, C. L., ROWE, P. C., VERHEUGT, F. W. & VISSER, F. C. 2020. Cognitive function
declines following orthostatic stress in adults with myalgic encephalomyelitis/ chronic fatigue syn-
drome (ME/ CFS). Front Neurosci, 14, 688.
VAN KOULIL, S., VAN LANKVELD, W., KRAAIMAAT, F. W., VAN HELMOND, T., VEDDER, A.,
VAN HOORN, H., DONDERS, R., DE JONG, A. J., HAVERMAN, J. F. & KORFF, K. J. 2010. Tailored
cognitive– behavioral therapy and exercise training for high‐risk patients with bromyalgia. Arthritis
Care Res, 62, 1377– 1385.
VANELZAKKER, M. B. 2013. Chronic fatigue syndrome from vagus nerve infection: A
psychoneuroimmunological hypothesis. Med Hypotheses, 81, 414– 423.
Infectious Disease and Neurocognition
VIGASOVA, D., NEMERGUT, M., LISKOVA, B. & DAMBORSKY, J. 2021. Multi- pathogen infections
and Alzheimer’s disease. Microb Cell Fact, 20, 1– 13.
WALITT, B., ČEKO, M., KHATIWADA, M., GRACELY, J. L., RAYHAN, R., VANMETER, J. W. &
GRACELY, R. H. 2016. Characterizing “brofog”: Subjective appraisal, objective performance, and
task- related brain activity during a working memory task. Neuroimage Clin, 11, 173– 180.
WESTERMEIER, F., LACERDA, E. M., SCHEIBENBOGEN, C. & SEPÚLVEDA, N. 2022. current in-
sights into complex post- infection fatigue syndromes with unknown aetiology: e case of myalgic
encephalomyelitis/ chronic fatigue syndrome and beyond. Front Med, 9, 408.
WHELTON, C., SALIT, I. & MOLDOFSKY, H. 1992. Sleep, Epstein- Barr virus infection, musculoskel-
etal pain, and depressive symptoms in chronic fatigue syndrome. J Rheumatol, 19, 939– 943.
WHITCROFT, K. L. & HUMMEL, T. 2020. Olfactory dysfunction in COVID- 19: Diagnosis and man-
agement. JAMA, 323, 2512– 2514.
WILD, C. J., NORTON, L., MENON, D. K., RIPSMAN, D. A., SWARTZ, R. H. & OWEN, A. M. 2022.
Disentangling the cognitive, physical, and mental health sequelae of COVID- 19. Cell Rep Med, 3,
100750.
WILLIAMSON, J. & LARNER, A. 2016. Cognitive dysfunction in patients with bromyalgia. Br J Hosp
Med, 77, 116– 116.
WOLFE, F. & RASKER, J. J. 2021. e evolution of bromyalgia, its concepts, and criteria. Cureus, 13,
e20010.
WOLFE, F., RASKER, J. J., TEN KLOOSTER, P., HÄUSER, W., RASKER, J. J. J. & KLOOSTER, P. 2021.
Subjective cognitive dysfunction in patients with and without bromyalgia: Prevalence, predictors,
correlates, and consequences. Cureus, 13, e20351.
WONG, K. H., SHAPIRO, E. D. & SOFFER, G. K. 2022. A review of post- treatment Lyme disease syn-
drome and chronic Lyme disease for the practicing immunologist. Clin Rev Allergy Immunol, 62,
264– 271.
WONG, T. L. & WEITZER, D. J. 2021. Long COVID and myalgic encephalomyelitis/ chronic fatigue
syndrome (ME/ CFS)— A systemic review and comparison of clinical presentation and symptomatology. Medicina, 57, 418.
WOOD, P. B., GLABUS, M. F., SIMPSON, R. & PATTERSON, J. C., 2ND. 2009. Changes in gray matter
density in bromyalgia: Correlation with dopamine metabolism. J Pain, 10, 609– 618.
WU, Y.- L., HUANG, C.- J., FANG, S.- C., KO, L.- H. & TSAI, P.- S. 2018. Cognitive impairment in bro-
myalgia: A meta- analysis of case– control studies. Psychosomat Med, 80, 432– 438.
YAMANISHI, K. 1992. Chronic fatigue syndrome and virus infection: Human herpesvirus 6 (HHV- 6)
infection. Nihon Rinsho, 50, 2612– 2616.
YANG, T. Y., LIN, C. L., YAO, W. C., LIO, C. F., CHIANG, W. P., LIN, K., KUO, C. F. & TSAI, S. Y. 2022.
How mycobacterium tuberculosis infection could lead to the increasing risks of chronic fatigue syndrome and the potential immunological eects: A population- based retrospective cohort study. J
Transl Med, 20, 99.
YUNUS, M., MASI, A. T., CALABRO, J. J., MILLER, K. A., & FEIGENBAUM, S. L. 1981. Primary -
bromyalgia (brositis): clinical study of 50 patients with matched normal controls. Semin Arthritis
Rheum, 11, 151– 171.
ZENEBE, Y., NECHO, M., YIMAM, W. & AKELE, B. 2022. Worldwide occurrence of HIV- associated
neurocognitive disorders and its associated factors: A systematic review and meta- analysis. Front
Psychiatry, 13, 814362.
ZUCKER, J., NEU, N., CHIRIBOGA, C. A., HINTON, V. J., LEONARDO, M., SHEIKH, A. &
THAKUR, K. 2017. Zika virus- associated cognitive impairment in adolescent, 2016. Emerg Infect
Dis, 23, 1047– 1048.
PART V
THE MICROBIOME AND NEUROCOGNITIVE
AND NEUROPSYCHIATRIC FUNCTION